Showing results (661-670 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|January 26, 2019
Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumorsAnna Schurich, Isabelle Magalhaes, Jonas MattssonImmunotherapy|February 1, 2019
Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantationJun Liu, Xi Zhang, Jiang F Zhong, et al.Immunotherapy|February 1, 2019
Biologics for hidradenitis suppurativa: an updateKatarzyna Włodarek, Małgorzata Ponikowska, Łukasz Matusiak, et al.Immunotherapy|February 18, 2020
Aggravation of depigmentation for a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: case reportYinghui Xu, Yangyang Cai, Jianjiao Zu, et al.Immunotherapy|February 18, 2020
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitorsShipra Gandhi, Manu Pandey, Nischala Ammannagari, et al.Immunotherapy|January 10, 2020
5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia - a summaryXian Zhang, Junfang Yang, Gailing Zhang, et al.Immunotherapy|February 5, 2019
Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysisAndrew M Frederickson, Stella Arndorfer, Ina Zhang, et al.Immunotherapy|January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisTeresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.Immunotherapy|January 5, 2019
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapyQing Li, Jingcao Huang, Yang Ou, et al.Immunotherapy|November 13, 2019
The efficacy of PD-1/PD-L1 inhibitors in advanced squamous-cell lung cancer: a meta-analysis of 3112 patientsRui-Lian Chen, Jing-Xu Zhou, Yang Cao, et al.Pageof 188